Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferoxamine for neurological and radiological outcomes after spontaneous intracerebral hemorrhage
IRCT20190325043107N30Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in intracerebral hemorrhage (ICH) comparing Deferoxamine with Placebo (2 arms). Primary endpoints: Level of consciousness, Neurological outcome and 1 more. Started May 2022; status: completed.
02
Drugs
deferoxamine
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on IRCT20190325043107N30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190325043107N30.